Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02421159 · ClinicalTrials.gov registry record · NA
Hybrid STTR Intervention for Heterosexuals: Anonymous Testing and Confidential Care Linkage
A NA study, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
NCT02421159 is a NA study that has completed, run by New York University. The registered enrollment target is 500 participants.
The verdict
NCT02421159, a NA study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
Study Summary
The Brooklyn Community United (BCU) study is a supplement to the main research study titled "Peer Driven Intervention to Seek, Test, \& Treat Heterosexuals at High Risk for HIV." The main study's field name is Brooklyn Community Action Project (BCAP) (R01DA032083, R#: 11-01257). The main study is testing two approaches to seeking out undiagnosed HIV infection (Venue-based Sampling (VBS) and Confidential Two-Session Testing with Navigation (CTTN-RDS)). HIV prevalence rates in two previous heterosexual cycles of NHBS in the local area are: 7% in HET1 and 12.3% in HET2. The main study, BCAP, found lower prevalence rates of 3.45%, 35.14% of which were newly diagnosed in the RDS-CTTN sample and 1.89% newly diagnosed with HIV in the VBS sample. The primary aim of the Brooklyn Community United (BCU) study is to seek out individuals with undiagnosed HIV using a streamlined RDS-CTTN approach, and anonymous HIV Testing in Central Brooklyn. The supplement study hypotheses are: (H1): Compared with VBS and RDS-CTTN, and controlling for potential differences on key socio-demographic characteristics across the samples, RDS-ASTN participants will have less HIV testing experience. (H2) Controlling for potential differences on key socio-demographic characteristics across the samples, RDS-ASTN will yield higher rates previously undiagnosed HIV compared with VBS and RDS-CTTN. (H3): Most participants (\> 70%) found to be HIV-infected in the RDS-ASTN intervention will engage in the Treat and Retain intervention phase. (H4): Most participants in the Treat and Retain phase of the RDS-ASTN intervention (\> 70%), all of whom will be HIV infected, will be linked to care within 3 months.
Interventions
- BEHAVIORAL Seek and Test Phase
- BEHAVIORAL Treat and Retain Phase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02421159
The ClinicalTrials.gov registry entry for NCT02421159 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Seek and Test Phase is the first listed.
NCT02421159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02421159 about?
NCT02421159 is a clinical study titled "Hybrid STTR Intervention for Heterosexuals: Anonymous Testing and Confidential Care Linkage". The Brooklyn Community United (BCU) study is a supplement to the main research study titled "Peer Driven Intervention to Seek, Test, \& Treat Heterosexuals at High Risk for HIV." The main study's field name is Brooklyn Community Action Project (BCAP) (R01DA032083, R#: 11-01257). The main study is te...
What is the current status of trial NCT02421159?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2015-02. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02421159?
The interventions under investigation include: Seek and Test Phase (BEHAVIORAL), Treat and Retain Phase (BEHAVIORAL).
Who is sponsoring clinical trial NCT02421159?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.